Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $2.15 Million - $2.8 Million
54,100 Added 9.22%
640,700 $33.2 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $7.36 Million - $9.69 Million
182,800 Added 45.27%
586,600 $24.4 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $8.8 Million - $9.98 Million
-183,400 Reduced 31.23%
403,800 $21.9 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $8.87 Million - $10.6 Million
183,000 Added 45.27%
587,200 $30.1 Million
Q3 2023

Nov 15, 2023

BUY
$57.89 - $64.73 $2.03 Million - $2.27 Million
35,000 Added 9.48%
404,200 $23.5 Million
Q2 2023

Aug 23, 2023

BUY
$63.71 - $70.74 $23.5 Million - $26.1 Million
369,200 New
369,200 $23.6 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $7,605 - $4.5 Million
58,500 Added 15.55%
434,600 $31.2 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $246,908 - $271,932
3,400 Added 0.91%
376,100 $29.4 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $10.8 Million - $12.9 Million
-175,500 Reduced 32.01%
372,700 $27.5 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $241,335 - $281,340
4,500 Added 0.83%
548,200 $34.3 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $4.43 Million - $5.19 Million
74,900 Added 15.98%
543,700 $33 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $7.78 Million - $8.47 Million
125,600 Added 36.6%
468,800 $31.1 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $4.32 Million - $4.86 Million
-72,800 Reduced 17.5%
343,200 $21.7 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $4.61 Million - $5.23 Million
79,900 Added 23.77%
416,000 $25.8 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $4.73 Million - $5.24 Million
-82,300 Reduced 19.67%
336,100 $20.1 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $6.52 Million - $7.63 Million
119,000 Added 39.75%
418,400 $24.2 Million
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $8.06 Million - $11.7 Million
-173,700 Reduced 36.72%
299,400 $16.3 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $12 Million - $15.7 Million
244,000 Added 106.5%
473,100 $30.2 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $2.17 Million - $2.57 Million
50,700 Added 28.42%
229,100 $11.5 Million
Q2 2019

Aug 20, 2019

SELL
$44.62 - $49.34 $30.3 Million - $33.5 Million
-678,100 Reduced 79.17%
178,400 $8.09 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $22.5 Million - $26.8 Million
498,200 Added 139.05%
856,500 $40.9 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $7.77 Million - $10.1 Million
159,300 Added 80.05%
358,300 $18.3 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $3.09 Million - $3.48 Million
-55,900 Reduced 21.93%
199,000 $12.4 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $2.89 Million - $3.32 Million
-48,200 Reduced 15.9%
254,900 $16.1 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $3.78 Million - $4.12 Million
-63,000 Reduced 17.21%
303,100 $18.6 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $20.2 Million - $23.3 Million
366,100
366,100 $23.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.